At hospital admission, the clinical and laboratory characteristics of patients largely overlapped, with clinical manifestations better differentiating patients with ADAMTS13 activity below and above 10% being hemorrhagic symptoms and renal failure. This evidence concerns the gene ADAMTS13 and kidney failure.